Bio-Rad Labs (BIO) PT Raised to $725 at Jefferies Noting the Sartorius Arbitrage Opportunity

February 5, 2021 8:41 AM EST Send to a Friend
Jefferies analyst Brandon Couillard raised the price target on Bio-Rad Labs (NYSE: BIO) to $725.00 (from $660.00) on the belief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login